Encompassing all Executive through Board Positions in Life Sciences

Director of the Board

Yes

Chief Executive Officer

Yes

Chief Business Officer

Leading publicly traded biopharmaceutical stem cell company.

No

Chairman of the Board

Yes

Chief Financial Officer

Formerly Aastrom Biosciences

Yes

Chief Operating Officer

Yes

Chief Scientific Officer

Leading publicly traded monoclonal antibody & oncology company

No

Executive Vice President, Orthopedics and Chief Operating Officer

Formerly BioMimetic Therapeutics, Inc.

Yes

In The News

GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand aliu Fri, 01/21/2022 – 09:50

New results show the effects of its next drug for transthyretin amyloidosis appear to hold up for a year and a half. But it's unclear whether treatment will help those with heart problems, a much larger market opportunity.  

After halting a Phase 3 trial of the drug last year, Roche went digging for more data. What it found led to plans for another trial, but the pharma's hypothesis may rest on shaky ground.

It’s a matter of national security: Sanofi doesn’t want new high-rise neighbors watching its Toronto plant kdunleavy Fri, 01/21/2022 – 10:25

Fierce JPM Week: Bristol Myers’ next-gen autoimmune med not just another JAK drug, exec says esagonowsky Fri, 01/21/2022 – 11:04

Poland’s largest pharma scouts for joint bidder in potential $4B buyout of former Sanofi generics unit: Reuters aliu Fri, 01/21/2022 – 11:30